Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice

Ketamine, a noncompetitive, voltage-dependent N-Methyl-D-aspartate receptor (NMDAR) antagonist, has been shown to have a rapid antidepressant effect and is used for patients experiencing treatment-resistant depression. We carried out a time-dependent targeted mass spectrometry-based metabolomics pro...

詳細記述

保存先:
書誌詳細
出版年:Mol Neuropsychiatry
主要な著者: Weckmann, Katja, Deery, Michael J., Howard, Julie A., Feret, Renata, Asara, John M., Dethloff, Frederik, Filiou, Michaela D., Labermaier, Christiana, Maccarrone, Giuseppina, Lilley, Kathryn S., Mueller, Marianne, Turck, Christoph W.
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger AG 2019
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465744/
https://ncbi.nlm.nih.gov/pubmed/31019917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493425
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料